Is there a role for a pure noradrenergic drug in the treatment of depression?
- 30 April 1997
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 7 (1), S3-S9
- https://doi.org/10.1016/s0924-977x(97)00414-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.BMJ, 1991
- Serotonin Function and the Mechanism of Antidepressant ActionArchives of General Psychiatry, 1990
- Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetineEuropean Journal of Pharmacology, 1988
- Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressantActa Psychiatrica Scandinavica, 1981
- Urinary MHPG Levels and Tricyclic Antidepressant Drug SelectionArchives of General Psychiatry, 1979
- Antidepressant Response to Tricyclics and Urinary MHPG in Unipolar PatientsArchives of General Psychiatry, 1975
- Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive CyclesScience, 1973
- Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patientsPsychological Medicine, 1972
- Catecholamine metabolism in affective disorders—III: MHPG and other catecholamine metabolites in patients treated with lithium carbonateJournal of Psychiatric Research, 1970